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Abstract
Toxoplasma gondii is an obligate intracellular parasite that is unique in its ability to infect a broad range of birds and
mammals, including humans, leading to an extremely high worldwide prevalence and distribution. This work focuses on the
environmentally resistant oocyst, which is the product of sexual replication in felids and an important source of human
infection. Due to the difficulty in producing and working with oocysts, relatively little is known about how this stage is able
to resist extreme environmental stresses and how they initiate a new infection, once ingested. To fill this gap, the proteome
of the wall and sporocyst/sporozoite fractions of mature, sporulated oocysts were characterized using one-dimensional gel
electrophoresis followed by LC-MS/MS on trypsin-digested peptides. A combined total of 1021 non-redundant T. gondii
proteins were identified in the sporocyst/sporozoite fraction and 226 were identified in the oocyst wall fraction.
Significantly, 172 of the identified proteins have not previously been identified in Toxoplasma proteomic studies. Among
these are several of interest for their likely role in conferring environmental resistance including a family of small, tyrosine-
rich proteins present in the oocyst wall fractions and late embryogenesis abundant domain-containing (LEA) proteins in the
cytosolic fractions. The latter are known from other systems to be key to enabling survival against desiccation.
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Introduction
Toxoplasma gondii is an important, zoonotic protozoan that can
infect a wide range of warm-blooded animals, including humans.
Domestic and wild felids are the only known definitive hosts in
which T. gondii undergoes sexual replication, resulting in the
formation of environmentally resistant oocysts [1,2]. Oocysts are
shed in cat feces and sporulate in the environment to become
infective to other hosts, including humans. An infected cat may shed
as many as one billion oocysts during a primary infection [1,3,4].
Oocysts are extremely durable and have been reported to survive
and remain infective for years in fresh water [5] and for at least
twenty-four months in salt water [6]. T. gondii has been emerging as
a significant waterborne pathogen of public health concern, as
outbreaks associated with the ingestion of contaminated water have
been reported globally, including in Panama (1979), Canada (1995),
French Guyana (1998), Brazil (2002) and India (2004) [7–11]. The
association of T. gondii with waterborne outbreaks has led to its
classification as a National Institute of Allergy and Infectious
Diseases (NIAID) Category B priority agent [12].
Toxoplasma gondii oocysts are resistant to chemical and physical
methods of inactivation used to treat waste-water and sewage [13–
16]. Two chemicals commonly used to treat water, sodium
hypochlorite (chlorine) and ozone, fail to completely inactivate
infective oocysts at concentrations well in excess of those typically
used to treat both sewage and drinking water [17,18]. Although
ultraviolet (UV) treatment has been shown to reduce oocyst viability,
doses of 40 to 500 mJ/cm2 irradiation failed to inactivate all oocysts
in treated water samples that were assessed by mouse bioassay
[19,20]. Even three years of storage in 2% sulfuric acid at 4uC leaves
oocysts still infective to mice (data not shown). What makes the
presence of these environmentally resistant oocysts an even greater
health concern is that the infectious dose is very low, with
experimental infections in mice and pigs resulting from exposure to
as few as 1–10 oocysts [21,22]. It is not known what structures in the
oocyst wall confer the resistance to extreme environmental stresses. It
is presumed that this is a result of structures present in one or both
layers of the oocyst wall, but this hypothesis has not been tested.
The approximately 67 Mb genome of Toxoplasma gondii has been
sequenced and predicts ,8,000 genes [23,24]. A number of
proteomic studies have been conducted on both subcellular and
whole Toxoplasma organisms, but these have all been limited to the
tachyzoite life stage [25–27] and only about 30% of the predicted
proteome has so far been detected [28,29]. Proteomic description of
the other life stages would increase the basis for validating gene
predictions and provide valuable foundational and comparative
data for functional analyses of identified proteins, all critical to
advancing our understanding of Toxoplasma biology.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29955
The aim of this study was to characterize the proteome of
mature Toxoplasma oocyst walls and sporocysts/sporozoites,
including bleach-treated versus non-bleach-treated samples to
discern inner from outer wall proteins. Many novel proteins were
identified in this way and the implications of our results for the
environmental resistance of oocysts are discussed.
Results
Proteomic identification of proteins in mature oocyst
fractions by LC-MS/MS
Our goal is to understand oocyst function, in particular its
extreme environmental resistance, through proteomic analysis of
its contents. To obtain duplicate samples for mass spectrometry,
two separate experiments using 100 million oocysts each were
conducted. In both experiments, oocyst walls and the sporocysts/
sporozoites within were separated prior to proteomic analysis. In
the second experiment, prior to wall and sporocyst/sporozoite
separation, the 100 million oocysts were divided into two groups
(50 million oocysts each), one that was treated with bleach to
remove the outer layer of the oocyst wall and the other that was
left untreated (Figures 1 and 2).
With the criterion of two-unique peptide identifications per
locus, a combined total of 1031 non-redundant proteins were
identified: 1021 proteins were identified in the sporocyst/
Figure 1. Flow chart showing experimental design for sample collection and processing of Toxoplasma gondii oocysts.
doi:10.1371/journal.pone.0029955.g001
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sporozoite fractions and 226 in the oocyst wall fraction (Table 1,
S1). Ten of the proteins identified in the wall fraction were not
detected in the sporocyst/sporozoite fractions. The ToxoDB
database contains a total of ,8000 predicted proteins. We
therefore detected ,13% of all predicted proteins in the
sporocyst/sporozoite fractions and ,2% in the oocyst wall
fractions. In both fractions, around 20% of the protein
identifications have not previously been reported when compared
with Toxoplasma tachyzoite MS data deposited at ToxoDB (v 6.4).
All 1031 proteins identified in each experimental group, with a
minimum of 2 unique peptides, are provided in Table S1. A
complete list of all peptides identified in each experiment,
including singlet peptides, is provided in Table S2. Proteins
identified here with a minimum of two unique peptides that have
not been previously identified in tachyzoites and reported on
ToxoDB (v 6.4) are listed in Table S3.
Abundantly detected proteins in sporocyst/sporozoite
fractions
Proteins with the highest spectral counts in the sporocyst/
sporozoite fractions, sorted on experiment one, were assembled to
produce a list of the 25 most-abundantly detected proteins in
sporocysts/sporozoites fractions (Table 2). Within this group of 25
proteins in the sporocyst/sporozoite fraction, there are several
interesting subsets. For example, many are known to be proteins
that pass through the parasite’s secretory pathways leading either
to the surface (glycolipid-anchored surface-antigen-one-related
sequences, or SRSs) or eventually to injection into the host cell
(rhoptry proteins, or ROPs and rhoptry neck proteins, or RONs)
or the parasitophorous vacuole (dense granule proteins, or GRAs).
Others are associated with cell recognition and adhesion (PAN-
domain-containing proteins, von Willebrand factor type A
domain-containing protein), movement and invasion (micronemes,
actin, myosin A), carbohydrate metabolism (LDH1 isoform of
lactate dehydrogenase, glyceraldehyde 3-phosphate dehydroge-
nase, and glucose-6-phosphate dehydrogenase) or other enzymes
(oxidoreductase). Also within the list of the 25 most abundantly
detected proteins are 5 hypothetical proteins. The list of all
proteins confidently detected in sporocysts/sporozoites (Table S1)
includes many more from these respective categories of proteins as
discussed further, below.
In a separate study (see accompanying manuscript), we
performed a quantitative comparison of the transcriptomes of
three major developmental stages of Toxoplasma: tachyzoites,
bradyzoites and oocysts. In the accompanying manuscript we
indicate if there was supporting proteomic evidence based on
proteins detected in this study. Proteomic evidence strongly
corroborates genes with high levels of mRNA detected by
microarray. To facilitate the discussion of this complex dataset,
we will divide the proteins into subsets based on their presumed
role and/or location within the parasite.
Surface antigens-SRSs. The surface antigen-1-related
sequences (SRSs) represent a gene family with similar structure
to the major, immunodominant surface antigen, SAG1, which is
abundantly expressed on tachyzoites. In the present study, 10 SRS
family proteins were detected in mature oocysts (Table 3). One
SRS protein was previously reported to be specifically enriched in
Figure 2. The Toxoplasma gondii oocyst and sporocyst walls are autofluorescent under UV excitation. A. Epifluorescent and bright field
images of intact, mature oocysts 10 days after exposure to maturing conditions showing intact oocysts (‘‘oocyst’’), isolated sporocysts (‘‘sporocyst’’),
and isolated oocyst walls (‘‘wall’’), the latter two fractions being derived from mature oocysts by glass bead disruption and gradient centrifugation as
detailed in the materials and methods. B. A detailed schematic of the oocyst components illustrating the absence of the outer layer of the oocyst wall
(ow) following treatment with bleach. The inner layer of the wall (iw) and sporocyst walls (Spw) remain intact following bleach treatment. The mature
oocyst contains two sporocysts, each with 4 sporozoites (spz).
doi:10.1371/journal.pone.0029955.g002
Table 1. Summary of LC-MS/MS spectral counts and protein
identification in sporocyst/sporozoite and oocyst wall
fractions of Toxoplasma gondii oocysts.
Experiment
One Experiment Two
No Bleach Bleach No Bleach Totals
Sporocysts/Sporozoites
Spectral counts 9613 4130 9463 23206
Protein identifications 886 438 710 1021
Decoy hits 1 0 3 4
False discovery rate 0.10% 0.00% 0.40% 0.40%
Oocyst Walls
Spectral counts 2072 275 1051 3398
Protein identifications 183 53 133 226
Decoy hits 0 0 0 0
False discovery rate 0.00% 0.00% 0.00% 0.00%
doi:10.1371/journal.pone.0029955.t001
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sporozoites and was designated SporoSAG [30] or SRS28. Based
on spectral counts shown in Table 2, this was the most abundantly
detected protein in our analysis in each of the three tested
sporozoite fractions across both experiments: 2.0% in Experiment
1 (NBT), 2.9% in Experiment 2 (NBT) and 3.8% in Experiment 2
(BT). The other SRS family genes identified in this dataset include
SRS57 (SAG3), SRS51 (SRS3), SRS46, SRS29B (SAG1),
SRS27B, SRS52A, SRS34A, SRS42 and a novel SRS domain-
containing protein. SAG3, SRS3 and SAG1 identified in this study
have previously been detected on sporozoites [30].
Secretory and invasion organelles (MICs, ROPs and
GRAs). The T. gondii family of microneme proteins share
structural domains associated with intermolecular interactions,
(e.g. PAN domains, von Willebrand factor type A domain or I-
domain), and are generally associated with parasite motility and
invasion of host cells. Several micronemal proteins were identified
in the present study, including: MIC1, MIC2, MIC2-associated
protein (M2AP), MIC3, MIC4, MIC6, MIC7, MIC8, MIC10,
MIC11, MIC12, MIC13, AMA1, an AMA1-paralogue
(TGME49_115730), and one putative microneme protein
(Table 4). Based on spectral counts, MIC12 and MIC13 were
the most abundantly detected micronemal proteins in sporocyst/
sporozoite fractions.
Rhoptries are secretory organelles that are discharged during
host-cell invasion. Once secreted, rhoptries may become associ-
ated with the moving junction, the parasitophorous vacuolar
membrane (PVM) or the host cell nucleus where they may play a
role in host cell invasion, establishment of the intracellular
parasitic niche or intersecting host-cell signaling pathways,
respectively [31–33]. In the present study, 19 rhoptry proteins
Table 2. LC-MS/MS spectral counts of abundantly detected proteins in Toxoplasma gondii sporocyst/sporozoite fractions.
Spectral Counts (% total spectral counts)
Experiment 1 Experiment 2
No Bleach Bleach No Bleach
Gene ID1 Protein Description2 Spor3 Wall3 Spor3 Wall3 Spor3 Wall3 Prior MS4
058550 SRS28 (SporoSAG) 192 (2.0) 26 (1.3) 157 (3.8) 29 (10.5) 273 (2.9) 27 (2.6) N
059670 von Willebrand factor type A
domain-containing protein
164 (1.7) 6 (0.3) 94 (2.3) 12 (4.4) 241 (2.5) 32 (3.0) N
009920 PAN domain-containing protein 135 (1.4) 12 (0.6) 94 (2.3) 19 (6.9) 184 (1.9) 34 (3.2) N
060190 microneme protein, putative 120 (1.2) 29 (1.4) 99 (2.4) 0 (0.0) 162 (1.7) 21 (2.0) Y
032350 lactate dehydrogenase (LDH1) 116 (1.2) 15 (0.7) 47 (1.1) 9 (3.3) 23 (0.2) 7 (0.7) Y
112630 hypothetical protein 113 (1.2) 17 (0.8) 109 (2.6) 2 (0.7) 143 (1.5) 2 (0.2) Y
003310 GRA7 109 (1.1) 17 (0.8) 73 (1.8) 11 (4.0) 99 (1.0) 17 (1.6) Y
035470 myosin A, putative 106 (1.1) 19 (0.9) 51 (1.2) 10 (3.6) 115 (1.2) 23 (2.2) Y
015780 Rhoptry kinase family
protein ROP2A
106 (1.1) 7 (0.3) 57 (1.40) 0 (0.0) 88 (0.9) 12 (1.1) Y
078830 glucose-6-phosphate
dehydrogenase, putative
103 (1.1) 7 (0.3) 40 (1.0) 8 (2.9) 66 (0.7) 8 (0.8) Y
067680 MIC12 93 (1.0) 2 (0.1) 119 (2.9) 2 (0.7) 156 (1.6) 5 (0.5) Y
106060 RON8 88 (0.9) 5 (0.2) 18 (0.4) 4 (1.5) 58 (0.6) 6 (0.6) Y
059900 hypothetical protein, conserved 84 (0.9) 19 (0.9) 40 (1.0) 4 (1.5) 126 (1.3) 14 (1.3) Y
108020 SRS57 83 (0.9) 13 (0.6) 26 (0.6) 7 (2.5) 114 (1.2) 17 (1.6) Y
094600 hypothetical protein 81 (0.80 63 (3.0) 43 (1.0) 0 (0.0) 71 (0.8) 6 (0.6) N
023920 RON3 80 (0.8) 0 (0.0) 29 (0.7) 0 (0.0) 68 (0.7) 5 (0.5) Y
089690 glyceraldehyde-3-phosphate
dehydrogenase
75 (0.80) 18 (0.9) 24 (0.6) 2 (0.7) 30 (0.3) 6 (0.6) Y
013280 hypothetical protein 74 (0.8) 16 (0.8) 36 (0.9) 7 (2.5) 114 (1.2) 14 (1.3) Y
009030 actin 74 (0.8) 11 (0.5) 41 (1.0) 12 (4.4) 56 (0.6) 13 (1.2) Y
070950 hypothetical protein 73 (0.8) 51 (2.5) 21 (0.5) 4 (1.5) 72 (0.8) 12 (1.1) N
108080 ROP5 69 (0.7) 10 (0.5) 32 (0.8) 0 (0.0) 74 (0.8) 10 (1.0) Y
110670 glycogen phosphorylase family
protein, putative
68 (0.7) 4 (0.2) 10 (0.2) 2 (0.7) 45 (0.5) 2 (0.2) Y
069120 oxidoreductase, putative 67 (0.7) 17 (0.8) 27 (0.7) 6 (2.2) 79 (0.8) 9 (0.9) N
000230 PAN domain-containing protein 61 (0.6) 9 (0.4) 38 (0.9) 0 (0.0) 32 (0.3) 2 (0.2) Y
086450 GRA5 59 (0.6) 4 (0.2) 31 (0.8) 0 (0.0) 79 (0.8) 4 (0.4) Y
The 25 most abundant proteins in the sporocyst/sporozoite fractions sorted according to highest spectral counts in experiment 1 sporocyst/sporozoite fraction.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein followed by the percentage that that number represents of all spectral counts in the sample indicated.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t002
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were identified (Table 5). Of these, ROP2A, RON8, RON3,
ROP5 and ROP42 were the five most abundant. Eight of the
rhoptry proteins detected were rhoptry neck proteins (RONs), and
one of these, RON2 is known to interact with AMA1 during
moving junction formation and invasion by tachyzoites, [31]. Two
RON2-paralogues, RON2L1 (TGME49_094400) and RON2L2
(TGME49_065120), were also detected. The three rhoptry bulb
proteins, ROP2A, ROP5 and ROP42 are part of a family with a
Table 3. LC-MS/MS spectral counts of functionally interesting proteins identified in sporocyst/sporozoite fractions of Toxoplasma
gondii oocysts – SRS family proteins.
Spectral Counts3
Experiment 1 Experiment 2
Gene ID1 Protein Description2 No Bleach Bleach No Bleach Prior MS4
058550 SRS28 (SporoSAG) 192 157 275 N
108020 SRS57 (SAG3) 83 26 114 Y
108840 SRS51 (SRS3) 43 10 76 Y
119350 SRS domain containing protein 31 21 44 Y
014190 SRS46 26 28 61 N
033460 SRS29B (SAG1) 17 7 18 Y
058810 SRS27B 11 5 8 N
115320 SRS52A 10 5 15 Y
071050 SRS34A (SAG2A) 7 0 9 Y
034370 SRS42 0 0 4 N
List of all SRS family proteins identified in sporocyst/sporozoite fractions.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t003
Table 4. LC-MS/MS spectral counts of functionally interesting proteins identified in sporocyst/sporozoite fractions of Toxoplasma
gondii oocysts – micronemal proteins.
Spectral Counts3
Experiment 1 Experiment 2
Gene ID1 Protein Description2 No Bleach Bleach No Bleach Prior MS4
060190 MIC13 120 99 162 Y
067680 MIC12 93 119 156 Y
001780 MIC2 51 29 54 Y
115730 AMA1-paralogue [SporoAMA1] 18 5 19 N
091890 MIC1 16 8 7 Y
055260 AMA1 14 5 18 Y
004530 MIC11 13 8 16 Y
014940 M2AP 10 8 7 Y
018520 MIC6 8 6 0 Y
050710 MIC10 7 4 18 Y
008030 MIC4 5 3 11 Y
045490 MIC8 4 0 3 Y
061780 MIC7 3 0 5 Y
119560 MIC3 2 0 11 Y
115550 microneme protein, putative 0 2 7 N
List of all micronemal proteins identified in sporocyst/sporozoite fractions.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t004
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conserved kinase-fold but all three are predicted to be catalytically
inactive ([34], ToxoDB.org)). Of these, ROP5 is best studied: it
associates with the PVM [35] and plays a crucial but still
unelucidated role in virulence [36–38]. ROP2A has been
suggested to play a role in recruitment of host mitochondria to
the PVM by tachyzoites [39] but questions about whether this is
indeed its function have recently been raised [40].
Dense granule proteins are discharged toward the end of the
invasion process and remain freely soluble or associate either with
the parasitophorous vacuolar membrane (PVM) or the membra-
nous intravacuolar network (IVN), which is linked to the PVM
[41]. They represent a diverse family of proteins with little stage-
specificity [42,43]. Their function is generally not well understood
but probably has to do with maintenance of the PVM. In vitro
studies indicate that upon entry into the host cell, sporozoites form
a temporary parasitophorous vacuole (PV1) before moving into a
second parasitophorous vacuole (PV2) where the majority of dense
granule proteins are secreted. GRA3 and GRA5 were previously
found to be secreted into PV1 and PV2, while NTPase, GRA1,
GRA2, GRA4, and GRA6 were exclusively secreted into PV2
[44]. All are abundantly present in the tachyzoite PV [44]. Eight
dense granule proteins were identified in the present dataset,
including GRA1, GRA2, GRA4, GRA5, GRA6, GRA7, GRA8
and GRA14 (Table 6).
Other proteins of interest. Additional proteins considered
to be of interest are listed in Table 7. Among these are four ‘‘late-
Table 5. LC-MS/MS spectral counts of functionally interesting proteins identified in sporocyst/sporozoite fractions of Toxoplasma
gondii oocysts – rhoptry proteins.
Spectral Counts3
Experiment 1 Experiment 2
Gene ID1 Protein Description2 No Bleach Bleach No Bleach Prior MS4
015780 ROP2A 106 57 88 Y
106060 RON8 88 18 58 Y
023920 RON3 80 29 68 Y
108080 ROP5 69 32 74 Y
009980 ROP42 57 19 68 Y
005250 ROP18 44 18 39 Y
014080 Toxofilin 37 41 62 Y
100100 RON2 30 6 28 Y
010110 ROP44 17 7 34 Y
065120 RON2L2 [SporoRON2] 14 2 19 N
029010 RON4 13 9 20 Y
027810 ROP11 13 8 10 Y
058580 ROP17 13 6 15 Y
075300 ROP2B 11 5 20 Y
091960 ROP40 11 3 2 Y
111470 RON5 10 7 19 Y
115220 ROP14 9 3 9 Y
109590 ROP1 8 5 17 Y
058370 ROP28 7 2 9 N
058660 ROP6 5 0 13 Y
052360 ROP24 5 0 7 Y
010090 ROP43 4 5 5 Y
089680 Rab11 2 2 0 Y
115490 ROP10 6 0 5 Y
003990 ROP12 4 2 0 Y
097960 RON6 2 0 3 Y
094400 RON2L1 6 0 2 N
011290 ROP15 5 0 0 Y
040090 ROP34 0 0 5 Y
058800 ROP31 0 0 2 Y
List of all rhoptry proteins identified in sporocyst/sporozoite fractions.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t005
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embryogenesis abundant domain-containing’’ (LEA) proteins that
have not previously been detected in proteomic studies of
bradyzoites and tachyzoites (as reported on ToxoDB v6.4). Two
metabolic enzymes (lactate dehydrogenase (LDH1) and enolase
(ENO2)) and a superoxide dismutase (SOD3) were also detected.
The two isoenzymes associated with carbohydrate metabolism,
LDH1 and ENO2, were previously reported to be abundantly
expressed in Toxoplasma tachyzoites but not bradyzoites [42,45,46].
Abundantly detected proteins in oocyst wall fractions
Fractionation allows information to be gleaned about a protein’s
likely location and, therefore, clues to its possible function. In
parallel to the analysis of the sporocyst/sporozoite fractions above,
we also analyzed fractions enriched for oocyst walls. The proteins
with the greatest number of spectral counts in these latter fractions
were two PAN-domain-containing proteins and a putative
oxidoreductase (Table 8). Also high on the list of abundant
proteins in the wall-enriched fractions were a putative micronemal
protein with PAN-domains (TGME49_054430), another PAN-
domain-containing protein, four tyrosine-rich hypothetical pro-
teins, a putative GPI transamidase subunit (PIG-U), a putative
oocyst wall protein (based on homology to a Cryptosporidium oocyst
wall protein), and a putative alanine dehydrogenase.
It is expected that wall components will also be detected within
sporocyst/sporozoite fractions because their deposition in the wall
could be a continuous process and so new material destined for
Table 6. LC-MS/MS spectral counts of functionally interesting proteins identified in sporocyst/sporozoite fractions of Toxoplasma
gondii oocysts – dense granule proteins.
Spectral Counts3
Experiment 1 Experiment 2
Gene ID1 Protein Description2 No Bleach Bleach No Bleach Prior MS4
003310 GRA7 109 73 99 Y
086450 GRA5 59 31 79 Y
039740 GRA14 17 7 23 Y
110780 GRA4 16 11 17 Y
075440 GRA6 9 7 20 Y
054720 GRA8 8 0 2 Y
070250 GRA1 4 0 9 Y
027620 GRA2 2 0 2 Y
List of all dense granule proteins identified in sporocyst/sporozoite fractions.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t006
Table 7. LC-MS/MS spectral counts of functionally interesting proteins identified in sporocyst/sporozoite fractions of Toxoplasma
gondii oocysts – other proteins of interest.
Spectral Counts3
Experiment 1 Experiment 2
Gene ID1 Protein Description2 No Bleach Bleach No Bleach Prior MS4
032350 LDH1 116 47 23 Y
068850 ENO2 38 31 30 Y
116190 Superoxide dismutase, putative (SOD3) 23 10 11 N
076860 late embryogenesis abundant domain-
containing protein
24 18 43 N
076850 late embryogenesis abundant domain-
containing protein (TgERP)
20 39 56 N
076880 late embryogenesis abundant domain-
containing protein
12 27 36 N
076870 LEA1 protein, putative 34 7 34 N
List of other proteins identified in sporocyst/sporozoite fractions that were considered to be of interest.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
doi:10.1371/journal.pone.0029955.t007
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this structure could be caught ‘‘in transit’’. As well, whenever
preparing subcellular fractions, a certain amount of contamination
in the separated fractions is inevitable. A very large ratio of
spectral counts in the oocyst wall relative to the sporocyst/
sporozoite fractions, however, should be indicative of a true
localization in the wall. Ten proteins were identified exclusively in
the wall fractions. To interrogate the specific enrichment of
abundant proteins detected in oocyst wall fractions, compared to
the sporocyst/sporozoite fraction within each experimental group,
a fold-enrichment calculation was made using the following
formula: [(spectral counts for a given protein in wall fraction)/
(total spectral counts in wall fraction)] divided by [(spectral counts
for a given protein in sporocyst/sporozoite fraction)/(total spectral
counts in sporocyst/sporozoite fraction)]. The protein identifica-
tions included in table 8 represented those with the most abundant
spectral counts identified in oocyst wall fractions and evidence of
enrichment in the walls (greater than 5-fold enrichment in walls in
at least one of the two ‘‘no bleach’’ samples, compared to
corresponding sporocyst/sporozoite fraction). Although not strictly
quantitative, the spectral counts mapping to a given protein relate
to the abundance of that protein and comparisons for an
individual protein, when made between the oocyst wall fractions
and sporocyst/sporozoite fractions, should not be substantially
affected by that protein’s size or ease of detection by MS [47].
Clearly, other factors can impact the detectability of a protein,
such as the abundance and nature of other proteins in the fraction,
but this approach provides at least an initial estimate of the relative
enrichment of a protein in the oocyst wall fractions.
Table 8. LC-MS/MS spectral counts of most abundantly detected proteins in Toxoplasma gondii oocyst wall fractions showing
spectral counts (% of all spectral counts) in each experimental group.
Spectral Counts (% total spectral counts)
Experiment 1 Experiment 2
No Bleach Bleach No Bleach
Gene ID1 Protein Description2 Wall3 Spor3 Fold4 Wall3 Spor3 Fold4 Wall3 Spor3 Fold4
Prior
MS5
035200 PAN domain-containing
protein
391 (18.9) 18 (0.2) 100.8 0 (0.0) 0 (0.0) N/A6 150 (14.3) 23 (0.2) 58.7 N
053150 oxidoreductase, putative 217 (10.5) 13 (0.1) 77.4 0 (0.0) 0 (0.0) N/A 147 (14.0) 45 (0.5) 29.4 N
035390 PAN domain-containing
protein
144 (6.9) 0 (0.0) N/C7 0 (0.0) 0 (0.0) N/A 41 (3.9) 3 (0.0) 123.1 N
054430 microneme protein,
putative
75 (3.6) 0 (0.0) N/C 0 (0.0) 0 (0.0) N/A 3 (0.3) 0 (0.0) N/C N
009470 hypothetical protein 36 (1.7) 35 (0.4) 4.8 5 (1.8) 13 (0.3) 5.8 17 (1.6) 65 (0.7) 2.4 N
035210 PAN domain-containing
protein
32 (1.5) 0 (0.0) N/C 0 (0.0) 0 (0.0) N/A 5 (0.5) 0 (0.0) N/C N
051910 hypothetical protein 29 (1.4) 0 (0.0) N/C 0 (0.0) 0 (0.0) N/A 2 (0.2) 4 (0.0) 4.5 N
077570 GPI transamidase subunit
PIG-U, putative
29 (1.4) 12 (0.1) 11.2 0 (0.0) 9 (0.2) 0.0 5 (0.5) 41 (0.4) 1.1 Y
037080 hypothetical protein* 27 (1.3) 3 (0.0) 41.8 2 (0.7) 5 (0.1) 6.0 2 (0.2) 4 (0.0) 4.5 N
094820 type I fatty acid
synthase, putative
18 (0.9) 12 (0.1) 7.0 0 (0.0) 0 (0.0) N/A 0 (0.0) 0 (0.0) N/A Y
087250 hypothetical protein* 13 (0.6) 3 (0.0) 20.1 0 (0.0) 3 (0.1) 0.0 3 (0.3) 3 (0.0) 9.0 N
081590 hypothetical protein* 12 (0.6) 6 (0.1) 9.3 0 (0.0) 13 (0.3) 0.0 10 (1.0) 20 (0.2) 4.5 N
003500 alanine dehydrogenase
putative
8 (0.4) 3 (0.0) 12.4 0 (0.0) 0 (0.0) N/A 0 (0.0) 0 (0.0) N/A N
069380 hypothetical protein 6 (0.3) 5 (0.1) 5.6 0 (0.0) 2 (0.0) 0.0 2 (0.2) 6 (0.1) 3.0 N
106050 hypothetical protein 5 (0.2) 4 (0.0) 5.8 3 (1.1) 4 (0.1) 11.3 4 (0.4) 0 (0.0) N/C N
048810 hypothetical protein 5 (0.2) 5 (0.1) 4.6 0 (0.0) 2 (0.0) 0.0 3 (0.3) 2 (0.0) 13.5 Y
058910 hypothetical protein 5 (0.2) 0 (0.0) N/C 0 (0.0) 0 (0.0) N/A 0 (0.0) 0 (0.0) N/A N
032170 hypothetical protein 5 (0.2) 0 (0.0) N/C 0 (0.0) 0 (0.0) N/A 0 (0.0) 7 (0.1) 0 Y
Abundant proteins in the oocyst wall fractions sorted first according to highest spectral counts in experiment 1 walls, then on fold-enrichment in wall fraction. Criteria
for inclusion in table are a minimum of 5 spectral counts in at least one of the wall fractions and a minimum of 5-fold-enrichment in one or both no bleach wall samples.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein in wall or sporocyst/sporozoite fraction.
4Fold-enrichment in the wall fraction. Calculation: [(spectral counts for a given protein in wall fraction)/(total spectral counts in wall fraction)] divided by [(spectral
counts for a given protein in sporocyst/sporozoite fraction)/(total spectral counts in sporocyst/sporozoite fraction)].
5Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
6N/A is ‘‘not applicable’’ and is designated when no fold enrichment exists because no spectral counts are detected in both wall and sporocyst/sporozoite fractions.
7N/C is ‘‘not calculable’’ and is designated when a zero is present in the denominator of the equation. Where N/C is reported spectral counts were detected in the wall
fraction and not the sporocyt/sporozoite fraction.
*Tyrosine-rich protein (.5% tyrosine).
doi:10.1371/journal.pone.0029955.t008
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Bleach-treatment has been reported to strip oocysts of the outer-
most layer of the wall [48] and so this treatment was applied to
half the starting material in experiment two; proteins present in the
outer layer of the oocyst wall should therefore be present in the
untreated samples but depleted in the bleach-treated material. We
found that following treatment with bleach, the total number of
spectral counts and protein identifications obtained for the wall
fraction dropped by 73.8% and 60.2%, respectively. Importantly,
however, bleach treatment appeared to reduce the sensitivity of
the assay overall as the spectral counts and protein identifications
in sporocyst/sporozoite fractions were also reduced following
bleach treatment by 56.4% and 38.3%, respectively. As a result,
conclusions about whether a given protein in the oocyst wall is
likely from the inner versus outer layers are tentative and limited to
those proteins where the differential was extreme; i.e., proteins
with very high spectral counts in both non-bleach-treated fractions
and zero spectral counts in the corresponding bleach-treated
fractions. Based on this criterion, the top three proteins listed in
Table 8 (two PAN domain-containing proteins, and a putative
oxidoreductase) appear most likely to be located in the outer layer
of the wall.
Tyrosine-rich, ‘‘Eimeria gam-like’’ proteins and oocyst
wall proteins
Prior to this work, the proposed model for oocyst wall
composition and formation in Toxoplasma was primarily derived
from studies describing the corresponding structure in the closely
related coccidian Eimeria. The Eimeria model relies upon the
presence of tyrosine-rich proteins that are believed to be cross-
linked via tyrosine residues through peroxidase activity [49]. A
BLAST search of the predicted Toxoplasma proteome (ToxoD-
B.org) with sequence similarity to two Eimeria wall proteins,
EmGam56 and EmGam82, failed to identify any compelling
homologues (data not shown). A search of the predicted Toxoplasma
proteome for tyrosine-rich proteins with a signal sequence,
however, did identify several hypothetical proteins. This was done
by searching all predicted proteins in the Toxoplasma proteome
found on ToxoDB (v6.4) for their amino acid content using tools
available at the following website: http://pir.georgetown.edu/
pirwww/search/comp_mw.shtml. The percent tyrosine cut-off
was set at 5% with the aim to capture those proteins near and
above the EmGam56 and 82 percentages, which are 8.6% and
9.7% tyrosine, respectively (determined from published translation
sequences: AAN05087.1 and AAO47083.2) [50,51]. Several
proteins with .5% tyrosine were identified by this search method.
Presented here are six that were both identified in the oocyst
proteome and also had supporting evidence of expression in the
oocyst stage by microarray (see accompanying manuscript). These
proteins were detected in the oocyst wall fractions analyzed in this
study (Table 9); however, they were also detected in the sporocyst/
sporozoite fractions. None of them have been detected in previous
reports of tachyzoite proteomes (ToxoDB v6.4). Because they were
detected in both sporocyst/sporozoite and oocyst wall fractions it
is not clear if these are oocyst wall components and/or sporocyst
wall components, or serve some other function.
Discussion
We report here the first comprehensive inventory of oocyst
proteins in Toxoplasma, with preliminary indications of which
proteins are in the oocyst wall versus the sporocyst/sporozoite
themselves and which of the wall proteins are inner versus outer
wall components. While a definitive conclusion about the location
of any one protein cannot be made from these data, there are
many trends that are unambiguous. Many proteins that have been
previously well studied in terms of location and function in
tachyzoites and bradyzoites were abundantly detected in our
oocyst data set. All of the previously described ‘‘tachyzoite-
specific’’ SRS proteins (i.e., abundantly expressed in tachyzoites
Table 9. LC-MS/MS spectral counts of tyrosine-rich (.5%) and putative oocyst wall proteins identified in sporocyst/sporozoite and
wall fractions of Toxoplasma gondii oocysts.
Experiment 1 Experiment 2
No Bleach Bleach No Bleach
Gene ID1 Protein Description2 Wall3 Spor3 Wall3 Spor3 Wall3 Spor3 Prior MS4
Tyrosine-rich proteins (% tyrosine)
116550 hypothetical protein (19.5%) 2 6 0 2 0 7 N
081590 hypothetical protein (15.5%) 12 6 0 13 10 31 N
087250 hypothetical protein (13.5%) 13 3 0 3 3 6 N
037080 hypothetical protein (6.2%) 27 3 2 5 2 9 N
120530 hypothetical protein (5.6%) 0 2 0 0 0 3 N
119890 hypothetical protein (5.5%) 9 50 10 70 22 47 N
Putative oocyst wall proteins
086250
(TgOWP6)5
oocyst wall protein, putative 30 36 0 18 12 44 N
009610
(TgOWP2)5
oocyst wall protein COWP,
putative
18 29 0 17 2 38 N
List of tyrosine-rich and putative oocyst wall proteins identified in wall and sporocyst/sporozoite fractions.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Number of spectral counts detected for a given protein in the wall and sporocyst/sporozoite fraction.
4Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
5Designations for COWP homologues in Toxoplasma by Possenti et al. [59].
doi:10.1371/journal.pone.0029955.t009
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but not bradyzoites), but none of the ‘‘bradyzoite-specific’’ SRS
proteins were identified in our data set. These findings are in
agreement with prior studies identifying SAG1, SAG3 and SRS3
on the surface of sporozoites [30] and strongly reinforce the
transcriptomic data in the accompanying manuscript that showed
sporozoites have more of a tachyzoite than bradyzoite phenotype
in terms of SRS gene expression.
The data reported here suggest that, as with the surface
antigens, the metabolic proteins of sporozoites may be more
similar to tachyzoites than bradyzoites. The ENO2 isoform of
enolase and LDH1 isoform of lactate dehydrogenase, which are
known to be much more abundantly expressed in tachyzoites
relative to bradyzoites, were detected in this oocyst study whereas
ENO1 and LDH2 that predominate in bradyzoites were not
detected [42,45,46]. This is not surprising given that immunolo-
calization studies of the ENO and LDH isoforms in bradyzoites
and tachyzoites and coccidian stages within the feline intestine
showed that, like tachyzoites, coccidian stages stain positive for
ENO2 and LDH1 and negative for the bradyzoite-abundant
ENO1 and LDH2 [46]. This may be an indication that the
metabolism of freshly sporulated sporozoites is both retained from
the intestinal sexual stages and is more similar to the rapidly
dividing tachyzoite than to the generally more quiescent
bradyzoite. Along similar lines, there appears to be a superoxide
dismutase isoform that is specific to the oocyst, SOD3 [52]. The
SOD3 isoform has not been detected in proteomic analyses of
tachyzoites (ToxoDB v6.4), suggesting a function unique to the
oocyst, perhaps protection against oxidative stresses experienced in
the environment.
The most abundantly detected microneme protein in our
dataset was MIC13. MIC13 is a recently described microneme
protein in T. gondii. It has three microneme adhesive repeat (MAR)
domains known to bind sialylated glycoconjugates on host cells
[53]. Conservation of the MAR domain among coccidian
enteroparasites suggests a specific role in enteric invasion; as such
it has been proposed that binding of sialylated glycoconjugates on
host cells facilitates invasion through the gut epithelium [53].
Another microneme protein possessing MAR domains is MIC1
[54]. It was shown in tachyzoites that MIC1 operates in a complex
with two other micronemal proteins, MIC4 and MIC6, to create
the TgMIC1-4-6 complex [55]. Each micronemal protein in the
MIC1-4-6 complex possesses unique domains, including MAR
domains in MIC1, Epidermal Growth Factor-like domains (EGF1)
in MIC6, and PAN-apple domains in MIC4 [55,56]. MIC13 was
shown to traffic to the micronemes independent of the MIC1-4-6
complex and it was proposed that it belongs to its own complex of
micronemal proteins [53]. Given the separate but synergistic roles
of the proteins in the MIC1-4-6 complex, it might logically follow
that MIC13 would similarly form complexes with other
micronemal proteins. Other micronemal proteins abundantly
detected in the sporocyst/sporozoite fractions that could
ostensibly participate in such a complex include: two microneme
proteins containing EGF domains, MIC12 and an additional,
putative microneme protein (TGME49_115550); a putative
microneme protein with PAN domains (TGME49_060190);
and two PAN-domain-containing proteins, (TGME49_009920
and TGME49_000230), which have not been localized to the
micronemes, requiring further investigation into their roles and
locations.
Transcriptomic analyses indicated that paralogues of two
proteins that are key to moving junction formation, AMA1 and
RON2, are expressed in sporozoites, at least at the RNA level (see
accompanying manuscript). These paralogues, dubbed Spor-
oAMA1 and SporoRON2, were readily detected in the oocyst
proteome reported here but so too were the original AMA1 and
RON2 proteins, as well as all the other members of the moving
junction complex, RON4, RON5 and RON8. This suggests that
sporozoites might have two options for forming a moving junction
during host-cell invasion. Dissecting the true functions of this
putative, alternative pairing will require extensive further work.
PAN domain-containing proteins are known to play a role in
protein-protein and protein-carbohydrate interactions [57]. The
structural conformation of PAN-domain containing proteins is
achieved through disulfide bridges resulting in a pattern of folding
that creates recognition and binding sites [58]. Two PAN domain-
containing proteins were uniquely abundant in the oocyst wall by
MS (TGME49_035200 and TGME49_035390) and two were
enriched in the sporocyst/sporozoite fractions (TGME49_009920
and TGME49_000230), the significance of which is not clear.
Current thinking is that sporozoites excyst from oocysts in the
gastric environment, followed by invasion into host intestinal cells
but these processes have not been studied in any detail in vivo.
Therefore, the possibility that the oocyst engages in host cell
recognition and enterocyte attachment prior to release of
sporozoites should not be excluded. In addition, it is possible that
the PAN domain-containing proteins in the wall are of structural
significance given their large size and predicted disulfide bridges.
As discussed above, a micronemal location for the PAN domain-
containing proteins in the sporozoite seems likely but has yet to be
demonstrated.
Studies of oocyst wall composition in the closely related
coccidian Eimeria and the gregarine-like Cryptosporidium have been
previously performed. Both an Eimeria-like oocyst wall, composed
of tyrosine-rich proteins held together by tyrosine cross-links, and
a Cryptosporidium-like oocyst wall, composed of cysteine-rich
proteins held together by disulfide bonds, are supported by our
data. Interestingly, the two OWPs (TgOWP2 and TgOWP6)
identified in the present study were detected in both the oocyst
wall and sporocyst/sporozoite fractions. The presence of OWPs in
the sporocyst/sporozoite and wall proteomes reported here could
reflect proteins in transit to the wall, although as the oocyst wall
appears to be fully formed in even immature oocysts, it seems
unlikely that they would still be being synthesized in mature
oocysts if this is their only purpose. Instead, it could be that these
proteins are part of the sporocyst wall, which is not present in
immature oocysts, or they could be exclusively oocyst wall proteins
and simply be contaminants of the sporocyst/sporozoite fractions
due, for example, to their large size, likely affinity with other
proteins and/or relative abundance. In support of the latter
explanation, TgOWPs 1, 2 and 3 were all previously identified as
oocyst wall, but not sporocyst wall, components [59], suggesting
that the TgOWP2 detected in the sporocyst/sporozoite fractions
was a contaminant from the wall fraction.
The finding of several tyrosine-rich proteins offers a possible
explanation for the observed autofluorescence of Toxoplasma
oocyst walls. The data here do not allow us to address whether
these proteins are cross-linked through their tyrosines (a linkage
known to produce autofluorescence) but their abundance and
location makes this a distinct possibility. Furthermore, the
peroxidase homologues detected in the oocyst wall fraction
(TGME49_053150) and the sporocyst/sporozoite fraction
(TGME49_069120) could provide the catalytic machinery in-
volved in the cross-linking. Resolution of both possibilities will
await more detailed structural and biochemical studies.
Sporocyst walls might be predicted to have similar proteins
because they are also autofluorescent. The tyrosine-rich proteins
described here were detected in both the wall and sporocyst/
sporozoite fractions. Enrichment calculations (Table 8) suggest
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that at least three of the tyrosine-rich proteins are enriched in the
oocyst wall fraction. We could not determine if the tyrosine-rich
proteins in the sporocyst/sporozoite fraction were a contaminant
or if they were in the sporocyst walls or sporozoites within.
Interestingly, the genes encoding the two tyrosine-rich proteins
most enriched in the oocyst wall were also most highly expressed
in d0 oocysts relative to d4 and d10, suggesting that these proteins
may be present at the time of wall formation, preceding formation
of sporocyst walls. Similarly, the genes encoding the two tyrosine-
rich proteins that appeared to be most enriched in sporocyst/
sporozoite fractions were most highly expressed in d4 oocysts, at
the time sporocysts are being formed. If this latter set of proteins is
in the sporocyst wall and if they do in fact play a role in structural
robustness and resistance to inactivation, it might be that these
structures provide an additional level of resistance to chemical and
physical inactivation.
A particularly intriguing group of proteins, designated ‘‘late-
embryogenesis abundant domain-containing’’ proteins (LEAs),
were identified here. While the function of these proteins in T.
gondii is unknown, LEA proteins have been described in a number
of other organisms including plants, invertebrates and microor-
ganisms [60]. There is significant diversity in the LEA families and
their respective functions are still under investigation. However, a
commonly ascribed role is in resistance to environmental stresses
including drought, high salinity and freezing [61]. One of the LEA
proteins in T. gondii was recently identified as a sporozoite-specific
antigen and named ‘‘Toxoplasma gondii embryogenesis-related
protein’’ (TgERP) and corresponds to the gene TGME49_076850
[62]. While it has been presumed that the T. gondii oocyst achieves
its resistance to environmental destruction through structures
present in the wall, the finding that the LEA proteins are both
abundant in oocysts and at least one is immunogenic to the host
implies that LEA proteins may be another critical component to
the oocyst that should receive further attention.
Further studies examining the oocyst through its development
will be useful to determine if oocyst wall composition changes as
the oocyst matures and sporulates once outside of the feline
definitive host and in the environment. There is reason to believe
that it might: the oocyst goes from very weakly autofluorescent
when first shed in feces as the unsporulated stage to intensely
autofluorescent at maturity as a sporulated oocyst (data not shown)
and the oocyst becomes more resistant to disinfectants as it
matures [63]. Whether additional proteins are incorporated as the
oocyst matures or if existing proteins are simply modified (e.g.
tyrosine cross-linked) is not known.
Functional analysis of newly identified proteins, such as the
LEAs, is also critical to advancing our understanding of the oocyst
as an environmentally resistant stage. The knowledge gained from
these studies will be useful to develop antibody-based methods for
oocyst concentration and detection in water, like those used in
Environmental Protection Agency-approved methods for Giardia
and Cryptosporidium, as well as strategies for more effective oocyst
inactivation that could be applied to water treatment. The
inventory of oocyst wall and internal oocyst proteins reported
here, 172 of which have not been previously detected in the
tachyzoite proteomes (Table S3), represents a crucial first step to
complete dissection of this under-studied but highly important
stage in the biology of Toxoplasma gondii.
Materials and Methods
Ethics statement
All kitten and mouse experiments were conducted conforming
to the guidelines of the Animal Welfare Act and the Health and
Research Extension Act. All experimental protocols specific to this
study were approved by the UC Davis Institutional Animal Care
and Use Committee (IACUC approval #15619), which is
accredited by the Association for Assessment and Accreditation
of Laboratory Animal Care International. Efforts were made to
minimize the numbers of animals used to generate Toxoplasma
organisms. The kittens used in the study remained healthy
throughout. After two weeks of confirmed absence of shedding
of Toxoplasma oocysts, the kittens were vaccinated and neutered,
then adopted out to pre-screened and approved permanent
homes.
Parasite Strain and Infection of Mice
As described in the accompanying manuscript (Fritz et al.,
submitted), for all of the studies described here, we used the M4
strain of T. gondii, originally isolated from an aborted sheep fetus
and kindly provided to our laboratory by Lee Innes of the
Moredun Research Institute, Edinburgh, Scotland. This isolate
was genetically characterized as a type II isolate (see accompany-
ing manuscript). To obtain oocysts for these experiments kittens
were infected by feeding infected mouse brains containing
bradyzoite cysts, as described in detail in accompanying
manuscript.
Oocyst Harvest from Kitten Feces and Sporulation
Kittens were screened for oocyst shedding and oocysts were
harvested from infected kitten feces using methods identical to
those described in the accompanying manuscript [64]. Briefly,
feces were examined for oocyst shedding by zinc sulfate double
centrifugation [3] and oocysts were harvested from feces by
sodium chloride flotation [17]. Concentrated oocyst pellets were
resuspended in approximately 12 ml of 2% sulfuric acid and
transferred to a T75 tissue culture flask for sporulation by aeration
and gentle shaking at room temperature (,22uC) for 10 days.
Oocyst Purification
Sporulated oocysts were collected from T75 sporulation flasks,
washed with PBS to restore neutral pH and purified using gradient
separation of oocysts with cesium chloride (CsCl) in Tris-EDTA
(TE) buffer (10 mM Tris-Cl, 1 mM EDTA, pH 7.4), as described
in accompanying manuscript. Purified oocysts were enumerated
using a hemocytometer and a total of 100 million oocysts were
used for each experiment.
Treatment with bleach to remove the outer-most layer of
the oocyst walls
In experiment two, 100 million oocysts were split into two
aliquots: bleach-treated (BT) and non-bleach treated (NBT).
Bleach-treated oocysts were suspended in 50% CloroxH bleach
(1:1 PBS and Clorox) and gently agitated at room temperature for
30 minutes. CloroxH contains 5–10% sodium hypochlorite. The
oocysts were then washed three times with PBS to remove bleach.
Oocyst Wall and Sporocyst Separation
CsCl-purified oocysts were disrupted using acid-washed glass
beads (350 mg, 200–400 mm, Invitrogen) in 1.5 ml screw-top
microcentrifuge tubes and vortexed at max speed in 20 sec
intervals until .90% of oocysts were broken open with visible
walls (roughly 60–120 sec total vortex time). Walls and sporocysts/
sporoblasts were purified using OptiPrep (SIGMA) reagents for
gradient separation, according to methods similar to those
previously described [65,66]. Oocyst walls were harvested at the
25%/30% interface and sporocysts were harvested at the 5%/
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15% interface. Walls and sporocysts were washed three times in
PBS, with the first two spins being done at 25006g for 15 min and
the pellets consolidated at each step. The pellet from the second
wash was transferred to a 1.5 ml microcentrifuge tube and a final
wash was done, spinning at 14,000 rpm for 8 min. Samples were
resuspended in 500 ml PBS and stored immediately at280uC until
processed for mass spectrometry.
Protein Preparation and Mass Spectrometry (MS)
In order to safely work with oocyst preparations in the MS
laboratory, it was necessary to inactivate oocyst materials and
demonstrate their non-infectivity. To do this, oocyst fraction
preparations were subjected to three freeze-thaw cycles, (2 minutes
each: 100% ethanol-dry ice bath followed by room temperature
water bath). Evaluation of this method in our laboratory
confirmed that oocysts were effectively inactivated as determined
by mouse bioassay.
1-D SDS-PAGE
Oocyst fractions, (1006106 oocyst equivalents in experiment
one and 506106 in each bleach-treated or not bleach-treated
sample in experiment two), were concentrated by filtration
through a 3 kDa filter, resuspended in 16 LDS lysis buffer
(lithium dodecyl sulfate, pH 8.4, Invitrogen) heated to 96uC for
5 min, and then separated on a 7 cm long, 4–12% NuPAGE Bis-
Tris gel (Invitrogen) in 16MES (2-(N-morpholino)ethanesulfonic
acid: 50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA,
pH 7.3, Invitrogen) running buffer. The gel was run at a constant
voltage (150 V) for approximately one hour. The entire length of
each sample lane was cut into 14, 0.5 cm, slices. Gel slices were
subjected to in-gel digestion with trypsin as described [67] before
analysis on an LTQ ion trap mass spectrometer (ThermoFisher).
LC-MS/MS
LC-MS/MS and subsequent analysis was performed as
described [68]. Briefly, peptides were separated on a Basic Picofrit
C18 capillary column coupled to an Eksigent nanoLC-2D
TM pump
before analysis on an LTQ ion trap mass spectrometer (Thermo-
Fisher). Peptides were eluted with an acetonitrile gradient from 0
to 60% in a 0.1% solution of formic acid over 2 hr. The flow rate
through the column was 250 nl/min and the spray voltage was
2.0 kV. Data-dependent scanning was employed allowing six MS2
scans of the most abundant ions of the parent full MS scan.
Dynamic exclusion was enabled for 180 sec.
Data Analysis
RAW files were generated for each gel slice by XCalibur (ver
2.0) running in conjunction with the mass spectrometer. These
were analyzed using the Sequest algorithm in Bioworks (ver 3.3)
software package. Searches were performed against a custom
concatenated target-decoy database containing the annotated
proteins based on the T. gondii ME49 release 5 sequences (http://
toxodb.org) and Cryptosporidium parvum database (http://cryptodb.
org). The C. parvum database was searched because prior to
infection with Toxoplasma, the kittens used in this experiment were
found to be shedding small numbers of Cryptosporidium oocysts in
their feces, as detected in the pre-infection screening of fecal
flotations. No Cryptosporidium oocysts were observed once Toxoplas-
ma oocysts were detected and subsequently harvested and purified.
Very few C. parvum protein matches were detected in the database
search and those were exclusively in abundant, highly conserved
proteins (e.g., ribosomal and heat shock proteins – see tables S1
and S2). Given that they were from such highly conserved
proteins, their exact biological origin could not be known with
certainty. Based on exclusion criteria in the analysis, all
identifications with a match in more than one database (CryptoDB
and ToxoDB) were removed from the analysis. The few
Cryptosporidium sequences that were identified were computation-
ally excluded from further analysis reported herein. It is possible
that other highly conserved proteins were identified in this dataset
and designated as either Cryptosporidium or Toxoplasma but may
have actually been peptides of another origin (ie. proteins from the
cat present in the samples) but were not excluded because that
database was not searched. Negative exclusion criteria could not
be run for the cat genome because it is not available. As a result of
the removal of highly conserved proteins in Toxoplasma and
Cryptosporidium, they will be under-represented in these data. As the
highly conserved proteins were not the focus of interest in this
study their exclusion are not expected to impact the conclusions.
SEQUEST data from each gel band were filtered and sorted using
DTASelect version 1.9 [69] under default settings. Peptides in the
+1, +2 and +3 charge-states were required to have minimum
XCorr values of 1.8, 2.5 and 3.5, respectively. The minimum
requirement for deltaCN was 0.08. Table S2 shows all peptides
identified. Both tryptic and semi-tryptic peptides are shown. The
false discovery rate (FDR) was determined according to the
guidelines of Elias and Gygi [70]. For the complete combined
peptide data, not including singlet peptides, the FDR was 0.19%.
For the complete protein identification (Table S1), the FDR was
0.85%. The FDR for all peptides detected, with singlet peptides
included, was 14%. In all discussion within the manuscript, only
the data with a requirement of two unique peptide identifications
per protein were considered.
Data Deposition
The data associated with this manuscript may be downloaded
from the ProteomeCommons.org Tranche network using the
following hash: Qw91UWAR++RGze0MZALyCRMob/x1n3Ng+
KsCQ284fZq2VnI9gr/Z0cnCfjAVo7KDt3503RYwfR2LYo0w/
WeVi6VHOJsAAAAAAABX7A= = . The peptide identifications
have also been made publicly available on ToxoDB (www.ToxoDB.
org).
Supporting Information
Table S1 All proteins identified by LC-MS/MS with a
minimum of two unique peptides.
(XLSX)
Table S2 All tryptic and semi-tryptic peptides identified
by LC-MS/MS, singlet peptides included.
(XLSX)
Table S3 All proteins identified for which no prior MS
evidence has been detected and reported on ToxoDB.org
(v6.4).
(XLSX)
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